Addisonian syndrome associated with treosulfan.
D000224:Addison Disease / Q000139:chemically induced*; D002066:Busulfan / Q000009:adverse effects / Q000031:analogs & derivatives*; D003536:Cystadenocarcinoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy
C018404:treosulfan; D002066:Busulfan